Here Is the Next Potential Market Catalyst
About 73% of the S&P 500 Names Beat on EPS During the Week - Earnings Scorecard
Notable Analyst Calls This Week: Disney, Super Micro and Amgen Among Top Picks
12 Out of 17 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard
Gilead Exits J&J Royalty Deal for Liver Drug Ahead of Potential FDA Nod
RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $72